medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2017, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2017; 33 (1)

Toward a national program for the collection and criopreservation of cord blood cells in Cuba

Rivero JRA

Language: Spanish
References: 47
Page: 1-19
PDF size: 320.28 Kb.


ABSTRACT

During the last 50 years, stem cell (SC) allogenic transplant has been an everyday most used form of treatment for the cure of malignant hemopathies and other nonmalignant diseases and genetic disorders, such as sickle cell disease and some primary immunodeficiency. Nevertheless, the lack of adequate donors caused by patients without histocompatible brothers or relatives has made it necessary to look for alternatives in "non-related" donors to guarantee the efficacy and security of transplants. A commonly used source is cord blood (CB); nowadays also known as a source of SC for regenerative medicine. Collection and cryopreservation in CB banks (CBB) have become a reality in many countries due to the importance of these treatments, and to their multiple advantages. Nevertheless, these facilities are subject to national and international regulations, guided by standards and accreditation process. Having a public CBB in Cuba is a need for the development of our National Health System which will allow us to solve the actual donor problem and will allow the international exchange in the struggle for a better public health care.


REFERENCES

  1. Bone Marrow Donors Worldwide. BMDW - Bone Marrow Donors Worldwide. The Netherlands. (Accedido en 04/08/2016). Disponible en http://www.bmdw.org.

  2. National Cord Blood Program. New York Blood Center.Cord Blood Donation. (Accedido: 09/08/2016). Disponible en: http://www.nationalcordbloodprogram. org/donation/why_donate_to_public_bank.html

  3. Smith AR, Wagner JE. Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. Br J Haematol. 2009 Oct; 147(2):246-61.

  4. Cao Fonticoba W. 2016: medio centenario del Instituto de Hematología e Inmunología. Rev Cubana Hematol Inmunol Hemoter. 2016;32(1):1-3

  5. Knudtzon S. In vitro growth of granulocyte colonies from circulating cells in human cord blood. Blood 1974; 43:357-361.

  6. Nakahata T, Ogawa M. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J Clin Invest 1983; 70:1324.

  7. Gluckman E, Broxmeyer HE, Auerbach AD. Hematopoietic reconstitution in a patient with Fanconi´s anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989; 321:1174.

  8. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000; 28:1197-205.

  9. Munoz J, Shah N, Rezvani K, Hosing C, Bollard CM, Oran B, et al. Concise review: umbilical cord blood transplantation: past, present, and future. Stem Cells Transl Med 2014;3:1435-43. doi:10.5966/sctm.2014-0151.

  10. National Cord Blood Program. List of diseases treated with NCBP units. New York Blood Center. (Accedido en 04-08-2016). Disponible en: http://www.nationalcordbloodprogram.org /patients/ncbp_diseases.pdf

  11. Garcia Lopez J. Situación actual de los bancos de sangre de cordón umbilical y su utilidad terapéutica. Acta Cient Tecnol. 2005; (9):37-9.

  12. Querol S, Rubinstein P, Marsh SEG, Goldman J, Madrigal JA. Cord blood banking: `providing cord blood banking for a nation. Br J Haematol. 2009; 147(2):227-35.

  13. Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, et al. Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant. 2011 Jan;46(1):70-6.

  14. Barker IN, Byam CE, Kernan NA, Lee SL, Hawke RM, Doshi KA, et al. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biol Blood MarrowTransplant. 2010 Nov; 16(11):1541-8.

  15. Mehta RS, Rezvani K, Olson A, Oran B, Hosing C, Shah N, et al. Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials. Front. Med. 2015; 2:89. doi: 10.3389/fmed.2015.0008.

  16. Rivero-Jiménez RA. Cultivos de expansión ex vivo de células madre a partir de sangre de cordón umbilical. Rev Argentina Transf. 2008; XXXIV (1,2):1-42

  17. Rivero-Jiménez RA. Razones para un banco de sangre de cordón umbilical en el Instituto de Hematología e Inmunología de Cuba. Rev Cubana Hematol Inmunol Hemoter. 2014 Mar; 30(1):4-10.

  18. Ballen KK, Koreth J, Chen YB, Dey BR, Spitzer TR. Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. Blood. 2012 Mar 1;119(9):1972-80.

  19. Breier DV, Querol S, García J. Alternativas terapéuticas en el post trasplante: Inmunoterapia adoptiva especifica de sangre de cordón (SCU) umbilical en el post transplante de células progenitoras hematopoyéticas. Acta Cientif Tecnol. 2006; (11):30-2.

  20. Shpall EJ , Quinones R , Giller R , Zeng C , Baron AE , Jones RB , et al., Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002; 8(7):368-76.

  21. Jaroscak J , Goltry K , Smith A , Waters-Pick B , Martin PL , Driscoll TA , et al., Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the Aastrom Replicell System. Blood. 2003;101(12): 5061-7.

  22. Petz LD, Redei I, Bryson Y, Regan D, Kurtzberg J, Shpall E, et al.Hematopoietic cell transplantation with cord blood for cure of HIV infections. Biol Blood Marrow Transplant. 2013; 19(3):393-7.

  23. Oh I-H, Lau A, Eaves CJ. During ontogeny primitive (CD34+CD38-) hematopoietic cells showed altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counter parts. Blood 2000; 96:4160-4168.

  24. Szilvassy SJ, Meyerrose TEJ, Ragland PL, Grimes B. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood 2001; 98:2108-2115.

  25. Rosler ES, Brandt JE, Chute J, Hoffman R. An in vivo competitive repopulation assay for various sources of human hematopoietic stem cell Blood 2000; 96:3414-342

  26. Ballen KK, Spitzer TR. The great debate: haploidenticalor cord blood transplant. Bone Marrow Transplant. 2011;46(3):323-9.

  27. Querol S. Cord blood banking: Current status. Hematology 2012; 17(S1):S185-8.

  28. Rubinstein P. Cord blood banking for clinical transplantation. Bone Marrow Transplant 2009; 44: 635-42.

  29. Armitage S. Cord Blood Banking Standards: Autologous Versus Altruistic. Front Med (Lausanne). 2015; 2: 94. doi: 10.3389/fmed.2015.00094

  30. Royal College of Gynecology. Umbilical Cord Blood Banking. Opinion Paper 2 (2001). (Accedido 04/08/2016). Disponible en: https://www.rcog.org/guidelines&researchservices/guidelines

  31. American Academy of Pediatrics. Cord blood banking for potential future transplantation. Pediatrics.2007;119:165-70. doi: 10.1542/peds.2006-2901.

  32. OPS. Legislación sobre donación y trasplante de órganos, tejidos y células: compilación y análisis comparado. Washington DC: OPS.2013. (Accedido en 15/7/2013). Disponible en: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=21392 &Itemid

  33. OMS. Principios Rectores de la OMS sobre Trasplante de Células, Tejidos y Órganos Humanos. Aprobados por la 63.ª Asamblea Mundial de la Salud, de mayo de 2010, en su resolución WHA63.22. (Accedido en 15/7/2013). Disponible en: http://www.who.int/transplantation/GuidingPrinciplesTransplantation_WHA63.22sp.pdf .

  34. Council of Europe. European Committee on Organ Transplantation. Umbilical Cord Blood Banking, a Guide for Parents. Strasbourg: European Directorate for the Quality of Medicines & HealthCare. 2015. (Accedido en 15/7/2016). Available from: https://www.edqm.eu/sites/default/files/parents_guide_to_umbilical_cord_blood_ban king_organ_transplantation_2015.pdf

  35. Querol S, Gomez SC, Pagliuca A, Torrabadella M, Madrigal JA. Quality rather than quantity: the cord blood bank dilemma. Bone Marrow Transplant. 2010; 45: 970-8.

  36. Sirchia G, Rebulla P, Mozzi F, Lecchi L, Lazzari L, Ratti I.A quality system or placental blood banking. Bone Marrow Transplant. 1998; 21 (Suppl 3):S43,

  37. Sirchia G, Rebulla P, Tibaldi S, LecchiL.Cost of umbilical cord blood units released for transplantation. Transfusion 1999; 39: 645.

  38. Querol S. Criopreservación y expansión "ex vivo" de progenitores hematopoyéticos de sangre de cordón umbilical y tejido amniótico para trasplantes no relacionados: III. Indicadores de calidad en el banco de cordón. Gac Méd Méx. 2003; 139 (Supl 3): S98-S101.

  39. Morera-Barrios LM, Jaime-Fagundo JC, Dorticós-Balea E, Ustáriz-García C, Hernández-Ramírez P. Células progenitoras hematopoyéticas de sangre de cordón umbilical. Rev Cubana Hematol Inmunol Hemoter. 2012 Jun; 28(2):130-40.

  40. FDA Center for Biologics Evaluation and Research (CBER). Guidance for Industry: Biologics License Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System. 2014. (Accedido en 15/7/2013). Available from: http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformatio n/Guidances/default.htm

  41. Keeney M, Chin-Yee I, Weir K, et al. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry. 1998;34:61-70.

  42. Gluckman E, Ruggeri A, Rocha V, Badoux E, Boo M, Kurtzberg J, et al. Familydirected umbilical cord blood banking. Hematologica. 2011; 96:1700-7. doi:10.3324/haematol.2011.047050

  43. Ustáriz García CR, Morera Barrios LM, Hernández Ramírez P, Estrada del Cueto M, Bencomo Hernández A, García García MA et al. Origen y composición genética de la población cubana. Rev Cubana HematolInmunolHemoter.2011; 27(3):273-82.

  44. Marcheco-Teruel B, Parra EJ, Fuentes-Smith E, Salas A, Buttenschøn HN, Demontis D, et al. Cuba: Exploring the History of Admixture and the Genetic Basis of Pigmentation Using Autosomal and Uniparental Markers. PLoS Genet. 2014 Jul 24;10(7):e1004488. doi: 10.1371/journal.pgen.1004488.

  45. Rivero-Jiménez RA. Nuevos estándares internacionales para terapia celular y trasplante de células de sangre de cordón umbilical. Rev Cubana Hematol Inmunol Hemoter. 2015 Mar; 31(1):65-70.

  46. Food and Drug Administration. CFR - Code of Federal Regulations Title 21. 2015. (Accedido en 15/7/2013) Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm

  47. Carlo P. European regulations on cord blood banking: an overview. Transfusion 2012;52:668-79. doi:10.1111/j.1537-2995.2011.03257.x




2020     |     www.medigraphic.com